Clinical Trial Update: Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lofexidine for managing opioid withdrawal in patients treated with extended-release naltrexone (XR-NTX) has completed with posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• LOFEXIDINE (LOFEXIDINE)
• XR-NTX (naltrexone extended-release injectable)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid-use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-12-09